share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  May 2 15:35
Summary by Moomoo AI
Arcutis Biotherapeutics, Inc. officer Todd Franklin Watanabe is set to sell 13,783 shares of common stock on 05/02/2024, as per the latest filing. The shares, valued at an aggregate market value of $120,432, were acquired through a restricted stock vest on 05/01/2024. This transaction follows a recent history of sales by Watanabe over the past three months, totaling 17,368 shares for gross proceeds of $191,868.
Arcutis Biotherapeutics, Inc. officer Todd Franklin Watanabe is set to sell 13,783 shares of common stock on 05/02/2024, as per the latest filing. The shares, valued at an aggregate market value of $120,432, were acquired through a restricted stock vest on 05/01/2024. This transaction follows a recent history of sales by Watanabe over the past three months, totaling 17,368 shares for gross proceeds of $191,868.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more